Finance

Beta
Lists
CL:NYSE
Colgate-Palmolive Co
$90.14
+0.74%
(+0.66) 1D
Jun 22, 12:22:14 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CL...
Open
$89.89
High
$90.80
Low
$89.41
Mkt. cap
72.13B
Avg. vol.
5.44M
Volume
1.39M
Dividend
2.35%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
34.98
52-wk high
$99.33
52-wk low
$74.54
EPS
$2.58
Beta
0.33
Shares outstanding
800.19M
No. of employees
34K
Open
$89.89
High
$90.80
Low
$89.41
Mkt. cap
72.13B
Avg. vol.
5.44M
Volume
1.39M
Dividend
2.35%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
34.98
52-wk high
$99.33
52-wk low
$74.54
EPS
$2.58
Beta
0.33
Shares outstanding
800.19M
No. of employees
34K
Analyst outlook
Analyst Ratings
Based on 18 analysts giving stock ratings to CL in the past 3 months
Buy
Buy
11
Hold
7
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for CL in the last 3 months.
Highest
Current $90.14
$105.00 (+16.48%)
Average
$96.00 (+6.50%)
Lowest
$80.00 (-11.25%)
News stories
From sources across the web
Profile
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products. Wikipedia
About Colgate-Palmolive Co
CEONoel R. Wallace | Noel R. Wallace
Employees33.6K
Founded1806
HeadquartersNew York, New York, United States
SectorHousehold goods
Websitecolgatepalmolive.com
Analyst Ratings
Based on 18 analysts giving stock ratings to CL in the past 3 months
Buy
Buy
11
Hold
7
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for CL in the last 3 months.
Highest
Current $90.14
$105.00 (+16.48%)
Average
$96.00 (+6.50%)
Lowest
$80.00 (-11.25%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Unknown Analyst
Bernstein
Hold
Initiated
$96.00
+6.5%
06/11/2026
Cristian Rios
Bernstein
Hold
Initiated
$96.00
+6.5%
06/11/2026
Taylor Conrad
Argus Research
Hold
Maintained
-
-
06/09/2026
Robert Ottenstein
Evercore ISI
Buy
Maintained
$100.00
+10.9%
06/08/2026
Dara Mohsenian
Morgan Stanley
Buy
Reiterated
$100.00
+10.9%
05/28/2026
Nik Modi
RBC Capital
Buy
Maintained
$102.00
+13.2%
05/14/2026
Lauren Lieberman
Barclays
Hold
Maintained
$80.00
-11.3%
05/05/2026
Peter Grom
UBS
Buy
Maintained
$100.00
+10.9%
05/04/2026
Robert Moskow
TD Cowen
Hold
Maintained
$85.00
-5.7%
05/04/2026
Stephen Powers
Deutsche Bank
Buy
Maintained
$99.00
+9.8%
05/04/2026
Andrea Faria Teixeira
J.P. Morgan
Buy
Reiterated
$96.00
+6.5%
05/04/2026
Andy Sim
DBS
Hold
Maintained
$95.00
+5.4%
05/03/2026
Bonnie Herzog
Goldman Sachs
Buy
Maintained
$100.00
+10.9%
05/01/2026
Kaumil Gajrawala
Jefferies
Hold
Maintained
$88.00
-2.4%
04/21/2026
Edward Lewis
Rothschild & Co Redburn
Buy
Upgraded
$100.00
+10.9%
04/21/2026
Filippo Falorni
Citi
Buy
Maintained
$105.00
+16.5%
04/15/2026
Peter Galbo
Bank of America Securities
Buy
Reiterated
$102.00
+13.2%
04/10/2026
Michael Lavery
Piper Sandler
Buy
Reiterated
$92.00
+2.1%
04/08/2026
Christopher Carey
Wells Fargo
Hold
Maintained
$92.00
+2.1%
04/08/2026
Last report
May 1, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.97 / $0.94
+2.70%beat
Revenue / Est. (USD)
5.32B / 5.22B
+2.08%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.11B
5.13B
5.23B
5.32B
Cost of goods sold
2.04B
2.08B
2.08B
2.10B
Cost of revenue
2.04B
2.08B
2.08B
2.10B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.99B
1.99B
2.00B
2.09B
Operating expense
2.00B
2.01B
2.08B
2.11B
Total operating expenses
4.04B
4.09B
4.16B
4.21B
Operating income
1.07B
1.04B
1.07B
1.11B
Other non operating income
-
-
-
-
EBT including unusual items
1.01B
992.00M
108.00M
892.00M
EBT excluding unusual items
1.02B
992.00M
1.04B
1.07B
Income tax expense
234.00M
226.00M
113.00M
211.00M
Effective tax rate
23.24%
22.78%
104.63%
23.65%
Other operating expenses
17.00M
19.00M
77.00M
21.00M
Net income
743.00M
735.00M
-37.00M
646.00M
Net profit margin
14.54%
14.32%
-0.71%
12.13%
Earnings per share
0.92
0.91
0.95
0.97
Interest and investment income
21.00M
21.00M
19.00M
16.00M
Interest expense
-71.00M
-67.00M
-64.00M
-62.00M
Net interest expenses
-50.00M
-46.00M
-45.00M
-46.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.22B
1.20B
1.24B
1.27B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer